ASX-listed ResMed climbs on upbeat quarterly results

ResMed

27/01/2023 24:22

** ASX-listed shares of U.S.- based ResMed Inc  RMD.AX 
climb up to 2.6% to A$33.8, hitting their highest since Dec. 5  
    ** Medical devices maker posts a quarterly net income of
$224.9 mln, compared with $201.8 mln same period last year 
    ** RMD says its quarterly revenue jumped 16% to $1.03 bln
    ** In 2022, stock lost 13.5%
 (Reporting by Navya Mittal in Bengaluru)
 ((navya.mittal@thomsonreuters.com))